U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Glick SB, Samson DJ, Huang E, et al. Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun. (Comparative Effectiveness Reviews, No. 102.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)

Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA) [Internet].

Show details

References

1.
Jevons MP. “Celbenin” - resistant Staphylococci. BMJ. 1961;1(5219):124–5.
2.
Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007 Dec;13(12):1840–6. [PMC free article: PMC2876761] [PubMed: 18258033]
3.
Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010 Aug 11;304(6):641–8. [PubMed: 20699455]
4.
Burton DC, Edwards JR, Horan TC, et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA. 2009 Feb 18;301(7):727–36. [PubMed: 19224749]
5.
Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003 Jan 1;36(1):53–9. [PubMed: 12491202]
6.
Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592–8. [PubMed: 12594640]
7.
Barton E, MacGowan A. Future treatment options for Gram-positive infections--looking ahead. Clin Microbiol Infect. 2009 Dec;15 Suppl 6:17–25. [PubMed: 19917023]
8.
Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998 Feb 25;279(8):593–8. [PubMed: 9486753]
9.
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002–2003. MMWR Morb Mortal Wkly Rep. 2003;52(5):88. [PubMed: 12588006]
10.
Methicillin-resistant Staphylococcus aureus among players on a high school football team--New York City, 2007. MMWR Morb Mortal Wkly Rep. 2009;58(3):52–5. [PubMed: 19177039]
11.
Ebert MD, Sheth S, Fishman EK. Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of “mayhem in the lung” Emerg Radiol. 2009 Mar;16(2):159–62. [PubMed: 18274797]
12.
Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis. 2002 Nov 1;186(9):1344–7. [PubMed: 12402206]
13.
Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest. 2007 Jan;87(1):3–9. [PubMed: 17146447]
14.
McAdams RM, Ellis MW, Trevino S, et al. Spread of methicillin-resistant Staphylococcus aureus USA300 in a neonatal intensive care unit. Pediatr Int. 2008 Dec;50(6):810–5. [PubMed: 19067897]
15.
Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006 Oct 9;166(18):1945–51. [PubMed: 17030826]
16.
Sheretz RJ, Reagan DR, Hampton KD, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med. 1996 Mar 15;124(6):539–47. [PubMed: 8597316]
17.
Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000 Oct 14;356(9238):1307–12. [PubMed: 11073019]
18.
Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on methicillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect. 2010 Mar;74(3):204–11. [PubMed: 20061061]
19.
Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008 Oct;29 Suppl 1:S12–21. [PubMed: 18840084]
20.
Jernigan JA, Titus MG, Groschel DH, et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 1996 Mar 1;143(5):496–504. [PubMed: 8610665]
21.
Srinivasan A, Song X, Ross T, et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol. 2002 Aug;23(8):424–8. [PubMed: 12186206]
22.
Mawdsley EL, Garcia-Houchins S, Weber SG. Back to basics: Four years of sustained improvement in implementation of contact precautions at a university hospital. Jt Comm J Qual Patient Saf. 2010 Sep;36(9):418–23. [PubMed: 20873675]
23.
Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003 Oct 8;290(14):1899–905. [PubMed: 14532319]
24.
Weber SG, Perl TM, Cosgrove SE. Quality of care and satisfaction among patients isolated for infection control. JAMA. 2004 Jan 28;291(4):421. author reply -2. [PubMed: 14747493]
25.
Vos MC, Behrendt MD, Melles DC, et al. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol. 2009 Oct;30(10):977–84. [PubMed: 19712031]
26.
Montecalvo MA, Jarvis WR, Uman J, et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol. 2001 Jul;22(7):437–42. [PubMed: 11583213]
27.
Price CS, Paule S, Noskin GA, et al. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis. 2003 Oct 1;37(7):921–8. [PubMed: 13130403]
28.
Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001 May 10;344(19):1427–33. [PubMed: 11346807]
29.
Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006 Oct 15;43(8):971–8. [PubMed: 16983607]
30.
Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008 Mar 18;148(6):409–18. [PubMed: 18347349]
31.
Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149–57. [PubMed: 18334690]
32.
Farr BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol. 2006 Oct;27(10):1096–106. [PubMed: 17006818]
33.
Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010 Jan 7;362(1):9–17. [PubMed: 20054045]
34.
Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint. SHEA and APIC Task Force. Am J Infect Control. 2007 Mar;35(2):73–85. [PubMed: 17327185]
35.
Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; Mar, 2011. AHRQ Publication No. 10(11)-EHC063-EF.
36.
Briss PA, Zaza S, Pappaioanou M, et al. Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med. 2000 Jan;18(1 Suppl):35–43. [PubMed: 10806978]
37.
Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001 Apr;20(3 Suppl):21–35. [PubMed: 11306229]
38.
Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii–x. 1–173. [PubMed: 14499048]
39.
Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010 May;63(5):513–23. [PubMed: 19595577]
40.
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res. 2004 Dec 22;4(1):38. [PMC free article: PMC545647] [PubMed: 15615589]
41.
Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011 Apr 14;364(15):1419–30. [PubMed: 21488764]
42.
Reilly JS, Stewart S, Christie P, et al. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. J Hosp Infect. 2012 Jan;80(1):31–5. [PubMed: 22104473]
43.
Leonhardt KK, Yakusheva O, Phelan D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infection Control and Hospital Epidemiology. 2011;32(8):797–803. [PubMed: 21768764]
44.
Gould IM, MacKenzie FM, MacLennan G, et al. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. Int J Antimicrob Agents. 2007 May;29(5):536–43. [PubMed: 17337163]
45.
Holzmann-Pazgal G, Monney C, Davis K, et al. Active surveillance culturing impacts methicillin-resistant Staphylococcus aureus acquisition in a pediatric intensive care unit. Pediatric Critical Care Medicine. 2011;12(4):e171–e5. [PubMed: 20838355]
46.
Huskins WC, Huckabee CM, O’Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011 Apr 14;364(15):1407–18. [PMC free article: PMC3410743] [PubMed: 21488763]
47.
Raineri E, Crema L, De Silvestri A, et al. Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect. 2007 Dec;67(4):308–15. [PubMed: 17945395]
48.
Blumberg LH, Klugman KP. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):82–5. [PubMed: 8168568]
49.
Boyce JM, Havill NL, Kohan C, et al. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol. 2004;25(5):395–401. [PubMed: 15188845]
50.
Clancy M, Graepler A, Wilson M, et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol. 2006;27(10):1009–17. [PubMed: 17006806]
51.
de la Cal MA, Cerda E, van Saene HK, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect. 2004 Mar;56(3):175–83. [PubMed: 15003664]
52.
Kurup A, Chlebicka N, Tan KY, et al. Active surveillance testing and decontamination strategies in intensive care units to reduce methicillin-resistant Staphylococcus aureus infections. Am J Infect Control. 2010 Jun;38(5):361–7. [PubMed: 20189267]
53.
Simmons S. Effects of selective patient screening for MRSA on overall MRSA hospital-acquired infection rates. Crit Care Nurs Q. 2011 Jan–Mar;34(1):18–24. [PubMed: 21160296]
54.
Souweine B, Traore O, Aublet-Cuvelier B, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect. 2000 Jun;45(2):107–16. [PubMed: 10860687]
55.
Muder RR, Cunningham C, McCray E, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2008 Aug;29(8):702–8. 7 p following 8. [PubMed: 18624651]
56.
Ellingson K, Muder RR, Jain R, et al. Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol. 2011 Jan;32(1):1–8. [PubMed: 21133794]
57.
Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int Orthop. 2005 Jun;29(3):160–3. [PMC free article: PMC3456888] [PubMed: 15864590]
58.
Jog S, Cunningham R, Cooper S, et al. Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect. 2008 Jun;69(2):124–30. [PubMed: 18387695]
59.
Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010 Aug 4;92(9):1820–6. [PubMed: 20610773]
60.
Lipke VL, Hyott AS. Reducing surgical site infections by bundling multiple risk reduction strategies and active surveillance. AORN J. 2010 Sep;92(3):288–96. [PubMed: 20816102]
61.
Malde DJ, Abidia A, McCollum C, et al. The success of routine MRSA screening in vascular surgery: a nine year review. Int Angiol. 2006 Jun;25(2):204–8. [PubMed: 16763540]
62.
Nixon M, Jackson B, Varghese P, et al. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br. 2006 Jun;88(6):812–7. [PubMed: 16720779]
63.
Pofahl WE, Goettler CE, Ramsey KM, et al. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg. 2009 May;208(5):981–6. discussion 6–8. [PubMed: 19476875]
64.
Sott AH, Jones R, Davies S, et al. The value of pre-operative screening for MRSA in the reduction of sepsis in total hip replacement associated with MRSA. A prospective audit. HIP Int. 2001;11(2):102–6.
65.
Supriya M, Shakeel M, Santangeli L, et al. Controlling MRSA in head and neck cancer patients: what works? Otolaryngol Head Neck Surg. 2009;140(2):224–7. [PubMed: 19201293]
66.
Thomas S, Cantrill S, Waghorn DJ, et al. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther. 2007 Mar 1;25(5):593–7. [PubMed: 17305760]
67.
Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011 Jan 10;171(1):68–73. [PubMed: 20837818]
68.
Kelly JC, O’Briain DE, Walls R, et al. The role of pre-operative assessment and ringfencing of services in the control of methicillin resistant Staphlococcus aureus infection in orthopaedic patients. Surgeon. 2012 Apr;10(2):75–9. [PubMed: 22385528]
69.
Chen AF, Chivukula S, Jacobs LJ, et al. What Is the Prevalence of MRSA Colonization in Elective Spine Cases? Clin Orthop Relat Res. 2012 Mar 23 [PMC free article: PMC3442011] [PubMed: 22441994]
70.
Chowers MY, Paitan Y, Gottesman BS, et al. Hospital-wide methicillin-resistant Staphylococcus aureus control program: A 5-year follow-up. Infect Control Hosp Epidemiol. 2009 Aug;30(8):778–81. [PubMed: 19580437]
71.
Harbarth S, Martin Y, Rohner P, et al. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2000 Sep;46(1):43–9. [PubMed: 11023722]
72.
Rodriguez-Bano J, Garcia L, Ramirez E, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol. 2010 Aug;31(8):786–95. [PubMed: 20524852]
73.
Bowler WA, Bresnahan J, Bradfish A, et al. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect Control Hosp Epidemiol. 2010 Mar;31(3):269–75. [PubMed: 20102280]
74.
Keshtgar MR, Khalili A, Coen PG, et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br J Surg. 2008 Mar;95(3):381–6. [PubMed: 18041109]
75.
Pan A, Carnevale G, Catenazzi P, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA “search and isolate” strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol. 2005;26(2):127–33. [PubMed: 15756881]
76.
Salaripour M, McKernan P, Devlin R. A multidisciplinary approach to reducing outbreaks and nosocomial MRSA in a university-affiliated hospital. Healthc Q. 2006 Oct;9(Spec No):54–60. [PubMed: 17087169]
77.
Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005;11(6):457–65. [PubMed: 15882195]
78.
Chaberny IF, Schwab F, Ziesing S, et al. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother. 2008 Dec;62(6):1422–9. [PubMed: 18765411]
79.
Eveillard M, Mortier E, Lancien E, et al. Consideration of age at admission for selective screening to identify methicillin-resistant Staphylococcus aureus carriers to control dissemination in a medical ward. Am J Infect Control. 2006;34(3):108–13. [PubMed: 16630972]
80.
Girou E, Azar J, Wolkenstein P, et al. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol. 2000 Sep;21(9):583–7. [PubMed: 11001261]
81.
Schelenz S, Tucker D, Georgeu C, et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect. 2005 Jun;60(2):104–10. [PubMed: 15866007]
82.
Thompson DS, Workman R, Strutt M. Decline in the rates of meticillin-resistant Staphylococcus aureus acquisition and bacteraemia in a general intensive care unit between 1996 and 2008. J Hosp Infect. 2009;71(4):314–9. [PubMed: 19217186]
83.
Trautmann M, Pollitt A, Loh U, et al. Implementation of an intensified infection control program to reduce MRSA transmissions in a German tertiary care hospital. Am J Infect Control. 2007 Dec;35(10):643–9. [PubMed: 18063128]
84.
West TE, Guerry C, Hiott M, et al. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol. 2006 Mar;27(3):233–8. [PubMed: 16532409]
85.
Enoch DA, Cargill JS, Sismey A, et al. MRSA surveillance in a UK district hospital: measuring clinical isolates with MRSA is more useful than measuring MRSA bacteraemias. J Hosp Infect. 2011 Dec;79(4):287–91. [PubMed: 21978609]
86.
Platt R. Time for a culture change? N Engl J Med. 2011 Apr 14;364(15):1464–5. [PubMed: 21488769]
87.
McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis. 2008 Jun 1;46(11):1717–25. [PubMed: 18494098]
88.
Tacconelli E, De Angelis G, de Waure C, et al. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis. 2009 Sep;9(9):546–54. [PubMed: 19695491]
89.
Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007 Dec;35(10 Suppl 2):S165–93. [PubMed: 18068814]
90.
Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003 May;24(5):362–86. [PubMed: 12785411]
91.
Harris AD, Bradham DD, Baumgarten M, et al. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004 Jun 1;38(11):1586–91. [PubMed: 15156447]
92.
Perencevich EN, Lautenbach E. Infection prevention and comparative effectiveness research. JAMA. 2011 Apr 13;305(14):1482–3. [PubMed: 21486981]
93.
Shardell M, Harris AD, El-Kamary SS, et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis. 2007 Oct 1;45(7):901–7. [PubMed: 17806059]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.0M)

Other titles in these collections

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...